Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Akso Health Group

Akso Health Group (HX) Stock Overview

Explore Akso Health Group’s financial performance, market position, analyst ratings, and future outlook.

HX●NASDAQ
HealthcareMedical - Distribution
$2.24
$0.10(4.27%)
U.S. Market opens in 64h 53m

Akso Health Group (HX)

Meyka AI Score

Z

Key Financials

Market Cap53.4M
P/E Ratio-1.05
EPS (TTM)$-1.22
ROE-1.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$8.10

HX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Akso Health Group (NASDAQ: HX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Akso Health Group's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $8.10 for the NASDAQ listing.

Key metrics behind Akso Health Group's NASDAQ-traded stock include a P/E ratio of -1.05 and a market capitalization of 53.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HX on the NASDAQ.

Price Performance (NASDAQ: HX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
37.42%
3-Year Change
-29.56%
5-Year Change
-29.56%
All-Time (Max) Change
-29.56%

Contact Information

https://www.xiaobaimaimai.com
861059856888
5Th Floor, Block C, Shimao No. 92 Jianguo Road Cha, Beijing, NaN, 100020

Company Facts

1,130 Employees
IPO DateNov 3, 2017
CountryCN

Frequently Asked Questions